North America, Europe and Asia-Pacific Women Sexual Wellness Market, By Test Type (Chlamydia Trachomatis And Neisseria Gonorrhoeae (CT/NG) Test, HCV Test, HIV Test, Cervical Cancer, Tuberculosis, Bacterial Vaginosis, Human Papillomavirus (HPV) Testing, Genital Herpes, Viral Complications With Transplant, and Others), Test Location (Over-The-Counter Testing, Self-Collection/ At Home Testing, Point-Of-Care Testing and Others), Technology (Molecular, Serology, Culture/ Isolation Of Organism, and Others), End User (Hospitals, Clinics, Diagnostic Centers, Laboratories, Home Care Setting, and Others), Distribution Channel (Online and Offline) - Industry Trends and Forecast to 2030.
North America, Europe and Asia-Pacific Women Sexual Wellness Market Analysis and Insights
The increasing awareness about the women's sexual wellness has enhanced the demand for the market. The rising healthcare expenditure for better health services also contributes to the market's growth. The major market players focus on various service launches and approvals during this crucial period. In addition, the increase in improved advancement of processes and techniques also contributes to the rising demand for women's sexual wellness.
The market is expected to grow in the forecast year due to the rise in market players and the availability of advanced services. Along with this, manufacturers are engaged in the developmental activity for launching novel services and efficient and accurate sexual health tests. The increasing development in advanced healthcare techniques is further boosting the market growth. However, difficulties such as the stringent regulations for producing and commercializing women's sexual wellness products are expected to restrain the market growth.
Increasing healthcare expenditure on advancement and development is expected to give opportunities to the market. However, the high cost of tests may challenge market growth.
Various companies are taking initiatives that gradually lead to the growth of the market:
For instance,
- In February 2023, BD a leading global medical technology company, announced the U.S. Food and Drug Administration (FDA) market approval for the BD Onclarity HPV Assay to be used with the ThinPrep Pap Test. This approval would help the company enhance products and research novel products
- In September 2020, F. Hoffmann-La Roche Ltd. announced the launch of the Elecsys HIV Duo immunoassay in the U.S., following FDA approval in April 2020. Through separate measurements of the HIV p24 antigen (the virus) and anti-HIV antibodies (caused by immune reaction), this test can detect an acute HIV infection. This product launch has helped the company in its product portfolio expansion
Data Bridge Market Research analyzes that the North America Women Sexual Wellness Market is expected to reach the value of USD 2,834.39 million by 2030, at a CAGR of 9.5% during the forecast period.
Data Bridge Market Research analyzes that the Europe Women Sexual Wellness Market is expected to reach the value of USD 1,484.16 million by 2030, at a CAGR of 8.7% during the forecast period.
Data Bridge Market Research analyzes that the Asia-Pacific Women Sexual Wellness Market is expected to reach the value of USD 1,277.82 million by 2030, at a CAGR of 10.3% during the forecast period.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customisble to 2015-2020)
|
|
Quantitative Units
|
Revenue in Million, Pricing in USD
|
|
Segments Covered
|
Test Type (Chlamydia Trachomatis And Neisseria Gonorrhoeae (CT/NG) Test, HCV Test, HIV Test, Cervical Cancer, Tuberculosis, Bacterial Vaginosis, Human Papillomavirus (HPV) Testing, Genital Herpes, Viral Complications With Transplant, and Others), Test Location (Over-The-Counter Testing, Self-Collection/ At Home Testing, Point-Of-Care Testing and Others), Technology (Molecular, Serology, Culture/ Isolation Of Organism, and Others), End User (Hospitals, Clinics, Diagnostic Centers, Laboratories, Home Care Setting, and Others), Distribution Channel (Online and Offline)
|
|
Countries Covered
|
U.S., Canada, Germany, France, U.K, China, Japan, and Australia
|
|
Market Players Covered
|
Trinity Biotech, BIOMÉRIEUX, Accuquik Test Kits., JOYSBIO (Tianjin) Biotechnology Co., Ltd, Arbor Vita, Randox Laboratories Ltd., Chembio Diagnostics, Inc., Cepheid., ELITech Group, Abbott, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Sekisui Diagnostics (A Part of SEKISUI Chemical Co. Ltd.), Quidel Corporation, BD., OraSure Technologies, Hologic, Inc., Biomed Diagnostics, and a DCN DX Brand among others.
|
North America, Europe and Asia-Pacific Women Sexual Wellness Market Definition
Women's sexual wellness refers to the overall well-being and satisfaction related to a woman's sexual health. Sexual diseases affecting women include various conditions such as Sexually Transmitted Infections (STIs) such as chlamydia, gonorrhea, herpes, Human Papillomavirus (HPV), and syphilis, and other conditions such as vaginal infections, Urinary Tract Infections (UTIs), Pelvic Inflammatory Disease (PID), and hormonal imbalances. The market for women's sexual wellness encompasses a range of diagnostic tools and methods, including laboratory tests, molecular diagnostics, point-of-care testing, imaging techniques, and specialized medical devices.
North America, Europe and Asia-Pacific Women Sexual Wellness Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- GROWING INCIDENCES OF SEXUALLY TRANSMITTED DISEASES
A severe global public health concern, sexually transmitted infections (STDs) are becoming more prevalent in diverse locations. The increased prevalence of STDs is significantly influencing the market for women's sexual wellness. It greatly impacts creating and expanding goods and services to enhance sexual health and well-being. Infertility, cervical cancer, and increased susceptibility to HIV are just a few of the long-term effects of STDs and the immediate health hazards they present. Promoting sexual welfare among women worldwide requires addressing the rising rates of STDs.
The followings are a few cases and instances of the rising STD prevalence in North America, Europe, and the Asia-Pacific area to throw light on how it affects the market for women's sexual well-being.
Restraint
- STIGMA AND SOCIAL TABOOS A CHALLENGE
Women's sexual wellness is stigmatized and socially taboo in North America, Europe, and Asia-Pacific, which poses a severe problem. Women encounter obstacles when attempting to access and seek out sexual health services and products due to these societal attitudes and beliefs.
In North America, societal stigma and taboos surrounding sexual matters may make it difficult to address or discuss women's sexual wellness publicly. This stigma may result from societal or religious expectations, which can cause guilt and concern about being judged. Women may be discouraged from seeking out sexual wellness-related information, education, and healthcare services by such attitudes.
In Europe, taboos and societal shame might prevent people from talking openly and accessing support for sexual health. Cultural, religious, and conservative forces may perpetuate the stigma around women's sexual health. Because of this stigma, women may be less likely to seek out sexual health treatments and be less able to make educated choices about their own bodies and sexual needs.
In Asia-Pacific, strongly ingrained cultural and societal standards frequently lead to stigmatization and taboos around women's sexual wellness. Patriarchal structures, conservative views, and limited access to comprehensive sexual education can facilitate the persistence of stigma. Women may hesitate to seek sexual health education, testing, and care out of concern about social stigma, parental or community disapproval, and judgment.
Opportunity
-
INCREASING PRODUCT APPROVALS AND PRODUCT LAUNCHES FOR SEXUAL WELLNESS
Increasing product approvals and product launches present a significant opportunity for the growth of the women's sexual wellness market. The availability of approved products enhances consumer confidence, assuring them of the offerings' safety, efficacy, and quality. It also expands treatment options, providing innovative solutions for conditions such as sexual dysfunction. With improved access and availability of these approved products, the market can reach a more extensive consumer base and address previously unmet needs. Furthermore, the approval and launch of new products stimulate research and innovation, pushing the boundaries of technology and driving market expansion.
Challenge
- LACK OF STANDARDIZATION, GUIDELINES, AND ETHICAL CONSIDERATIONS
The women's sexual wellness market faces a critical issue characterized by the lack of standardization and ethical considerations. This absence of robust guidelines and regulations poses significant challenges for consumers and the industry. One of the primary concerns is the inconsistent quality of products available in the market. In addition, the absence of standardized testing protocols hampers the scientific validation of these products, leading to limited evidence-based knowledge and hindering informed decision-making.
Inconsistent Product Quality: The absence of standardized regulations has led to a wide variation in the quality of women's sexual wellness products in the market. This lack of consistency can jeopardize consumer safety and satisfaction, potentially leading to adverse health effects or ineffective results.
Recent Developments
- In March 2023, Trinity Biotech plc welcomed the Kenyan Ministry of Health's announcement of adopting a new HIV rapid testing algorithm. This new algorithm establishes Trinity Biotech’s TrinScreen HIV as the screening test (A1 = screen test under World Health Organisation (WHO) guidelines)
- In May 2022, Quidel Corporation (“QuidelOrtho”) announced the completion of the transaction combining Quidel Corporation (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (“Ortho”), creating QuidelOrtho, a leading in vitro diagnostics company. The new company is headquartered in San Diego, California. This merger would also help the company expand its business in the clinical diagnostic segment.
North America, Europe and Asia-Pacific Women Sexual Wellness Market Scope
North America, Europe and Asia-Pacific women sexual wellness market is segmented into five notable segments such as test type, test location, technology, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE
- CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST
- HCV TEST
- HIV TEST
- CERVICAL CANCER
- TUBERCULOSIS
- BACTERIAL VAGINOSIS
- HUMAN PAPILLOMAVIRUS (HPV) TESTING
- GENITAL HERPES
- VIRAL COMPLICATIONS WITH TRANSPLANT
- OTHERS
On the basis of test type, the market is segmented into Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) test, HCV test, HIV test, cervical cancer, tuberculosis, bacterial vaginosis, Human Papillomavirus (HPV) testing, genital herpes, viral complications with transplant, and others.
NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION
- OVER-THE-COUNTER TESTING
- SELF-COLLECTION/AT HOME TESTING
- POINT-OF-CARE TESTING
- OTHERS
On the basis of test location, the market is segmented into over-the-counter testing, self-collection/ at home testing, point-of-care testing, and others.
NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY
- MOLECULAR
- SEROLOGY
- CULTURE/ISOLATION OF ORGANISM
- OTHERS
On the basis of technology, the market is segmented into molecular, serology, culture/ isolation of organism, and others.
NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY END USER
- HOSPITALS
- CLINICS
- DIAGNOSTIC CENTERS
- LABORATORIES
- HOME CARE SETTING
- OTHERS
On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, laboratories, home care setting, and others.
NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL
- ONLINE
- OFFLINE
On the basis of distribution channel, the market is segmented into online and offline.
North America, Europe and Asia-Pacific Women Sexual Wellness Market Regional Analysis/Insights
The market is categorized into five notable segments: test type, test location, technology, end user, and distribution channel.
The countries covered in this market report are U.S., Canada, Germany, France, U.K., China, Japan, and Australia.
The U.S. is expected to dominate the market in North America segment due to the high prevalence of sexual-related diseases such as HIV and HCV in the region. Germany is expected to dominate the market in the Europe segment due to a rise in healthcare expenditure. China is expected to dominate the market in Asia-Pacific segment due to the rising awareness of sexual health.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and North America, Europe and Asia-Pacific Women Sexual Wellness Market Share Analysis
North America, Europe and Asia-Pacific Women Sexual Wellness market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breath, application dominance, product type lifeline curve. The above data points provided are only related to the company’s focus on the North America, Europe and Asia-Pacific Women Sexual Wellness market.
Some of the major market players operating in the market are Trinity Biotech, BIOMÉRIEUX, Accuquik Test Kits., JOYSBIO (Tianjin) Biotechnology Co., Ltd, Arbor Vita, Randox Laboratories Ltd., Chembio Diagnostics, Inc., Cepheid., ELITech Group, Abbott, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Sekisui Diagnostics (A Part of SEKISUI Chemical Co. Ltd.), Quidel Corporation, BD., OraSure Technologies, Hologic, Inc., Biomed Diagnostics, and a DCN DX Brand among others.
SKU-